Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Bill Wexler's Profits of DOOM -- Ignore unavailable to you. Want to Upgrade?

To: Bill Wexler who wrote (2589)	9/10/1998 7:29:00 PM
From: Druss	Read Replies (1) \| Respond to of 4634

Bill--A little DD for the HEPH fans. This company purports to be working on HIV, Hepatitis B and C, malaria, antiparasitic compounds, and antifungal compounds. This means they have drugs in the works that impact every type of microscopic woe that Pandora released on the world. They are doing it with unparalleled efficiency, they have nine employees. Supposedly going to announce results soon in second or third week of September. This is an ongoing promise made several times for several different dates in the past. SEC filings promise substantial and ongoing expenses for the foreseeable future. All the Best Druss